The Consumer Financial Protection Bureau, the so-called cop on the beat protecting Americans from financial abuse, is now under strict orders to do nothing.

The Consumer Financial Protection Bureau has been a go-to financial agency for dealing with bad practices. Trump ...

A top Wells Fargo executive said on Tuesday that the bank has five consent orders remaining to resolve issues related to its ...

The card earns bonus points for travel and dining-related spending, which can be redeemed for more value through Chase. It piles on the perks, too, but they come at a price. With a big sign-up ...

Shares in CBA, Australia's biggest bank, have soared nearly 70% since November 2023 when the central bank lifted interest ...

We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at where JPMorgan Chase & Co.

(Bloomberg) -- The nation’s biggest office-to-residential conversion is hitting the market with 1,300 apartments carved from a million-square-foot brick fortress originally built to house ...

For JP Morgan Chase ... and 4,500 branches. JPMorgan Chase does not break out specific revenue or profit figures for Chase Auto, and instead reports it as part of a broader category covering both auto ...

Meanwhile, the consumer business continues to show strength through solid debit and credit card ... Federal Reserve's future moves that could impact the stock. Beyond these factors, JPMorgan's ...

a former JPMorgan Chase banker, alleged the firm “misrepresented” several indicators used to assess its complexity by the Federal Reserve by engaging in a process called “netting,” which is prohibited ...

In this podcast, Motley Fool contributor Matt Frankel and host Mary Long break down big bank earnings. They also discuss: Why comparisons to 2023 give banks more credit than they may deserve. The ...

During his presentation at the J.P. Morgan Healthcare Conference last week ... “We will be turning a lot of these cards during the year,” Hoppenot said during an interview with Fierce Pharma ...